MedPath

Comparison of ADR Using NBI Versus HD White Light Colonoscopy in Screening and Surveillance Colonoscopies

Not Applicable
Completed
Conditions
Narrow Band Imaging
Interventions
Device: HD white light or NBI
Registration Number
NCT03081975
Lead Sponsor
Jena University Hospital
Brief Summary

The aim of this study is to compare ADR using HD-NBI or HD-WLE during screening and surveillance colonoscopies.

Detailed Description

Background:

Despite recent advances in endoscopic technology adenoma miss rate still is up to 20% and contributes to the occurrence of interval cancers. Therefore, improved imaging modalities have been introduced to increase adenoma detection rate (ADR) during screening and surveillance colonoscopies. Recently, narrow band imaging (NBI; Exera II series, Olympus Corporation) was not significantly better than high definition white light colonoscopy (WLC) for the detection of patients with colorectal polyps, or colorectal adenomas1. However, Olympus' current Exera III series is characterized by better illumination of the bowel lumen and may be associated with a higher ADR than high definition WLC.

Methods:

Investigators performed a prospective evaluation in patients referred to the Department of Interdisciplinary Endoscopy at Jena University Hospital for screening or surveillance colonoscopy between January and November 2015 in daily clinical practice. Colonoscopy was performed by use of HD-WLC or HD-NBI upon withdrawal of the colonoscope (Exera III series, Olympus Corporation).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Screening colonoscopies
Exclusion Criteria
  • Insufficient bowel cleansing
  • Age under 55years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HD narrow band imagingHD white light or NBIColonoscopy was performed by use of HD-WLC or HD-NBI upon withdrawal
HD white lightHD white light or NBIColonoscopy was performed by use of HD-WLC or HD-NBI upon withdrawal
Primary Outcome Measures
NameTimeMethod
Adenoma detection rateup to 60min

Adenoma detection rate

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Clinic Jena

🇩🇪

Jena, Thueringia, Germany

© Copyright 2025. All Rights Reserved by MedPath